Related Experiment Video

Updated: Jun 21, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

Genetic and epigenetic regulations of prostate cancer by genistein

Benoit Molinié1, Philippe Georgel

  • 1Cell Differentiation and Development Center, Marshall University, Huntington, West Virginia, USA.

Drug News & Perspectives
|July 18, 2009
PubMed

Insights

Genistein, found in soy, influences gene expression and epigenetics, potentially reducing prostate cancer risk. This review explores its dietary impact on cancer-related genetic and epigenetic pathways.

Area of Science:

  • Oncology
  • Epigenetics
  • Nutritional Science

Background:

  • Prostate cancer gene regulation involves more than DNA mutations, pointing to epigenetic mechanisms.
  • Epigenetic factors like DNA methylation and chromatin structure play crucial roles.
  • Dietary compounds, such as genistein from soy, may modulate these epigenetic changes.

Purpose of the Study:

  • To review the current understanding of genistein's effects on gene expression.
  • To explore genistein's role in modulating epigenetic mechanisms in prostate cancer.
  • To summarize genistein's impact on biological pathways relevant to prostate cancer.

Main Methods:

  • Literature review of studies on genistein, epigenetics, and prostate cancer.
  • Analysis of research on genistein's molecular mechanisms.
  • Synthesis of epidemiological and experimental findings.

Main Results:

  • Genistein exhibits anticancer properties and is linked to lower prostate cancer incidence in epidemiological studies.
  • Genistein modulates DNA methylation and chromatin structure.
  • Genistein affects gene expression and biological pathways involved in prostate cancer.

Conclusions:

  • Genistein holds potential as a dietary intervention for prostate cancer prevention and treatment.
  • Understanding genistein's epigenetic effects is key to leveraging its therapeutic benefits.
  • Further research is warranted to fully elucidate genistein's role in prostate cancer biology.

More Related Videos

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

miRNA Expression Analyses in Prostate Cancer Clinical Tissues11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...